NLS Pharmaceutics AG

NASDAQ: NLSP · Real-Time Price · USD
1.47
-0.03 (-2.00%)
At close: Apr 28, 2025, 3:50 PM
-2.00%
Bid 1.36
Market Cap 3.63M
Revenue (ttm) n/a
Net Income (ttm) -2.04M
EPS (ttm) -6.74
PE Ratio (ttm) -0.22
Forward PE 0.03
Analyst n/a
Ask 1.47
Volume 5,475
Avg. Volume (20D) 1,952,586
Open 1.48
Previous Close 1.50
Day's Range 1.47 - 1.50
52-Week Range 1.30 - 18.40
Beta -0.22

About NLSP

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to ...

Industry Biotechnology
Sector Healthcare
IPO Date Jan 29, 2021
Employees 6
Stock Exchange NASDAQ
Ticker Symbol NLSP
Full Company Profile

Advertisement

4 weeks ago
+18.46%
NLS Pharmaceutics shares are trading higher after ... Unlock content with Pro Subscription
2 months ago
+37.43%
NLS Pharmaceutics shares are trading higher after the company announced it will join forces with Kadimastem for diabetes treatment.